Estimated reading time: seven (7) minutes
US/Silver Spring: Lupin Pharmaceuticals Inc., a Baltimore, Maryland establishment, recalls certain batch/lots of Tydemy Contraception Tablets from the American marketplace due to reported low levels of Ascorbic Acid (an inactive ingredient) and high levels of a known impurity with consequential risks of unexpected pregnancy, all serious health and safety hazards requiring immediate medical intervention to minimize pain and suffering as well as prevent life-altering injury or death.
FDA: https://rb.gy/puc8u
Additional information:
The US Food and Drug Administration (“FDA”) reports the following Oral Contraception products are subject to this recall:
Filed under: Anaphylaxis, Contraception | birth control, Drugs, Food & Drink, US FDA | Tagged: Birth Control Pills, drug, drug failure hazard, Inmar Rx Solutions Inc., Lupin Pharmaceuticals Inc., Recalls Direct RIN: 17416-2023, Tydemy Contraception Tablets, unplanned pregnancy hazard, US FDA, US Food and Drug Administration | Leave a comment »